That’s precisely why I say 2 years give or take for Nanose. Unless of course it is trialled over the current period for already known Covid negatives for other diseases. However, if so, it will still take possibly years of trials and data before it is adopted on a wider scale.
Therefore, with the current status of BRN chip testing of the first production batch, the green light for EAP partners to start using the first volume production chips for testing and adoption into their own devices, 1-2 years is a fair time frame to expect an end product that is produced, approved for use, and available for commercial sale.
IMO DYOR.
2021 BRN Discussion, page-26779
-
- There are more pages in this discussion • 6,802 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $343.4M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 18.5¢ | 16.5¢ | $1.865M | 10.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 1001708 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 167790 | 3 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| BRN (ASX) Chart |